0000000000620658

AUTHOR

Eberhard Kochs

showing 7 related works from this author

Sevoflurane affects neurogenesis after forebrain ischemia in rats.

2007

BACKGROUND: The effect of sevoflurane on the neuroregenerative potential after neuronal injury is unclear. We investigated the effect of low and high concentrations of sevoflurane on endogenous neurogenesis after cerebral ischemia. METHODS: Anesthetized and ventilated rats were randomized to four different treatment groups. Groups 1 and 2: 1.4% sevoflurane; Groups 3 and 4: 2.8% sevoflurane. In Groups 1 and 3, no cerebral ischemia was induced (sham-operated). In Groups 2 and 4, 10 min of forebrain ischemia was induced by bilateral carotid artery occlusion plus hemorrhagic hypotension. Physiological variables were maintained constant. Bromodeoxyuridine was given as a marker of neurogenesis. A…

MaleMethyl EthersIschemiaH&E stainHippocampusHippocampusSevofluraneBrain IschemiaRats Sprague-Dawleychemistry.chemical_compoundRandom AllocationSevofluraneProsencephalonmedicineAnimalsCell ProliferationNeuronsDose-Response Relationship Drugbusiness.industryDentate gyrusNeurogenesismedicine.diseaseNerve RegenerationRatsDose–response relationshipDisease Models AnimalAnesthesiology and Pain MedicinechemistryAnesthesiaAnesthetics InhalationDentate GyrusbusinessBromodeoxyuridinemedicine.drugAnesthesia and analgesia
researchProduct

Sevoflurane Impairs Cerebral Blood Flow Autoregulation in Rats: Reversal by Nonselective Nitric Oxide Synthase Inhibition

2005

UNLABELLED In this study, we investigated the effects of 1.0 and 2.0 minimum alveolar anesthetic concentration (MAC) sevoflurane on cerebral blood flow (CBF) autoregulation before and after nonselective inhibition of nitric oxide (NO) synthase in rats. Rats were randomly assigned as follows: Group 1 (n = 8): 1.0 MAC sevoflurane; Groups 2 and 3 (n = 8 per group): 2.0 MAC sevoflurane. Assessment of autoregulation within a mean arterial blood pressure range of 140-60 mm Hg was performed by graded hemorrhage before and after administration of l-arginine methyl ester (l-NAME, 30 mg/kg IV, Groups 1 and 2) or during hypocapnia (Group 3). In 10 additional animals, brain tissue NO(2)(-) concentratio…

Methyl EthersBlood PressureVasodilationPharmacologyNitric OxideSevofluraneNitric oxideRats Sprague-DawleySevofluranechemistry.chemical_compoundHypocapniaAnimalsHomeostasisHyperventilationMedicineAutoregulationEnzyme InhibitorsCerebral HemorrhageBrain ChemistryBlood VolumeDose-Response Relationship Drugbiologybusiness.industrymedicine.diseaseRatsNitric oxide synthaseNG-Nitroarginine Methyl EsterAnesthesiology and Pain MedicineCerebral blood flowchemistryCerebrovascular CirculationAnesthesiaAnesthetics InhalationAnestheticbiology.proteinNitric Oxide Synthasebusinessmedicine.drugAnesthesia & Analgesia
researchProduct

Dose-dependent effect of S(+) ketamine on post-ischemic endogenous neurogenesis in rats.

2009

Background: Ketamine is a non-competitive antagonist at N-methyl-d-aspartate (NMDA) receptors and reduces neuronal injury after cerebral ischemia by blocking the excitotoxic effects of glutamate. However, cerebral regeneration by means of endogenous neurogenesis may be impaired with blockade of NMDA receptors. The effects of S(+) ketamine on post-ischemic neurogenesis are unknown and investigated in this study. Methods: Thirty-two male Sprague–Dawley rats were randomly assigned to the following treatment groups with intravenous S(+) ketamine anesthesia: S(+) ketamine 0.75 mg/kg/min with or without cerebral ischemia and S(+) ketamine 1.0 mg/kg/min with or without cerebral ischemia. Eight non…

Malemedicine.medical_specialtyNeurogenesisIschemiaHippocampusReceptors N-Methyl-D-AspartateBrain IschemiaRats Sprague-DawleyInternal medicinemedicineAnimalsKetamineDose-Response Relationship Drugbusiness.industryDentate gyrusNeurogenesisAntagonistGlutamate receptorGeneral Medicinemedicine.diseaseRatsAnesthesiology and Pain MedicineEndocrinologyAnesthesiaNMDA receptorKetaminebusinessExcitatory Amino Acid Antagonistsmedicine.drugActa anaesthesiologica Scandinavica
researchProduct

Influence of Propofol on Neuronal Damage and Apoptotic Factors after Incomplete Cerebral Ischemia and Reperfusion in Rats

2004

Background Propofol reduces neuronal damage from cerebral ischemia when investigated for less than 8 postischemic days. This study investigates the long-term effects of propofol on neuronal damage and apoptosis-related proteins after cerebral ischemia and reperfusion. Methods Male Sprague-Dawley rats were randomly assigned as follows: group 1 (n = 32, control): fentanyl and nitrous oxide-oxygen; group 2 (n = 32, propofol): propofol and oxygen-air. Ischemia (45 min) was induced by carotid artery occlusion and hemorrhagic hypotension. Pericranial temperature and arterial blood gases were maintained constant. After 1, 3, 7, and 28 postischemic days, brains were removed, frozen, and sliced. Hi…

medicine.medical_specialtybusiness.industryIschemiaHippocampal formationmedicine.diseaseNeuroprotectionFentanylBrain ischemiaAnesthesiology and Pain MedicineEndocrinologyApoptosisAnesthesiaInternal medicinemedicineArterial bloodPropofolbusinessmedicine.drugAnesthesiology
researchProduct

Serial Measurement of Static and Dynamic Cerebrovascular Autoregulation After Brain Injury

2011

In patients with neuronal injury, the knowledge of the status of cerebrovascular autoregulation can help to optimize the management of the cerebral perfusion pressure. This study characterizes dynamic and static cerebrovascular autoregulation during the first 7 days after severe traumatic brain injury or intracranial hemorrhage.After approval from the IRB, 16 patients were studied. Cerebral blood flow velocity (CBFV) was measured daily for the assessment of dynamic (10 patients) and static (16 patients) cerebrovascular autoregulation in both the middle cerebral arteries using the transcranial Doppler sonography. Dynamic cerebrovascular autoregulation (dAR) was measured using the cuff-deflat…

AdultMaleUltrasonography Doppler TranscranialBlood PressureYoung AdultText miningHomeostasisHumansMedicinecardiovascular diseasesCerebral perfusion pressureAgedbusiness.industryMiddle AgedAnesthesiology and Pain Medicinenervous systemCerebrovascular autoregulationBrain InjuriesCerebrovascular CirculationAnesthesiaFemaleSurgeryNeurology (clinical)UltrasonographybusinessAlgorithmsJournal of Neurosurgical Anesthesiology
researchProduct

Machine learning for a combined electroencephalographic anesthesia index to detect awareness under anesthesia

2020

Spontaneous electroencephalogram (EEG) and auditory evoked potentials (AEP) have been suggested to monitor the level of consciousness during anesthesia. As both signals reflect different neuronal pathways, a combination of parameters from both signals may provide broader information about the brain status during anesthesia. Appropriate parameter selection and combination to a single index is crucial to take advantage of this potential. The field of machine learning offers algorithms for both parameter selection and combination. In this study, several established machine learning approaches including a method for the selection of suitable signal parameters and classification algorithms are a…

Support Vector MachinePhysiologyComputer scienceElectroencephalographycomputer.software_genreField (computer science)Machine Learning0302 clinical medicineLevel of consciousnessAnesthesiology030202 anesthesiologyMedicine and Health SciencesAnesthesiamedia_commonClinical NeurophysiologyAnesthesiology MonitoringBrain MappingMultidisciplinaryArtificial neural networkmedicine.diagnostic_testPharmaceuticsApplied MathematicsSimulation and ModelingQUnconsciousnessRElectroencephalographyNeuronal pathwayddc:ElectrophysiologyBioassays and Physiological AnalysisBrain ElectrophysiologyAnesthesiaPhysical SciencesEvoked Potentials AuditoryMedicinemedicine.symptomAlgorithmsAnesthetics IntravenousResearch ArticleComputer and Information SciencesConsciousnessImaging TechniquesCognitive NeuroscienceSciencemedia_common.quotation_subjectNeurophysiologyNeuroimagingAnesthesia GeneralResearch and Analysis MethodsBayesian inferenceMachine learningMachine Learning Algorithms03 medical and health sciencesConsciousness MonitorsDrug TherapyArtificial IntelligenceMonitoring IntraoperativeSupport Vector MachinesmedicineHumansMonitoring Physiologicbusiness.industryElectrophysiological TechniquesBiology and Life SciencesSupport vector machineStatistical classificationCognitive ScienceNeural Networks ComputerArtificial intelligenceClinical MedicineConsciousnessbusinesscomputerMathematics030217 neurology & neurosurgeryNeurosciencePLOS ONE
researchProduct

Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Regist…

2019

BACKGROUND: We compared, through the European Liver Transplant Registry, long-term liver transplantation outcomes with prolonged-release tacrolimus (PR-T) versus immediate-release tacrolimus (IR-T)-based immunosuppression. This retrospective analysis comprises up to 8-year data collected between 2008 and 2016, in an extension of our previously published study. METHODS: Patients with <1 month follow-up were excluded; patients were propensity score matched for baseline characteristics. Efficacy measures included: univariate/multivariate analyses of risk factors influencing graft/patient survival up to 8 years posttransplantation, and graft/patient survival up to 4 years with PR-T versus IR-T.…

Graft RejectionMalemedicine.medical_specialtyTime FactorsDrug Compoundingmedicine.medical_treatmentCalcineurin InhibitorsMedizinMEDLINEchemical and pharmacologic phenomenaLiver Transplant030230 surgeryLiver transplantationRisk AssessmentTacrolimusall contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA)03 medical and health sciences0302 clinical medicineRisk FactorsProlonged releaseInternal medicinemedicineHumansAged; Calcineurin Inhibitors; Delayed-Action Preparations; Drug Compounding; Europe; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Male; Middle Aged; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome; Liver TransplantationRegistriesAgedRetrospective StudiesTransplantationbusiness.industryGraft SurvivalImmunosuppressionRetrospective cohort studyMiddle AgedTacrolimusSettore MED/18Liver Transplantation3. Good healthEuropeTreatment Outcomesurgical procedures operativeDelayed-Action PreparationsFemale030211 gastroenterology & hepatologyTransplant patientbusinessRisk assessmentImmunosuppressive AgentsTransplantation
researchProduct